口腔癌治療薬の世界市場（2022年～2026年）

世界の口腔癌治療薬の市場規模は、2022年～2026年の間に11億4,000万米ドルの増加が見込まれ、予測期間中に7.5％のCAGRで成長が予測されているものの、減速傾向にあります。

同市場は、口腔癌の発生率と有病率の増加、口腔癌のリスク要因の増加、口腔癌に関する意識の高まりによって牽引されています。

当レポートでは、世界の口腔癌治療薬市場について調査し、市場規模や予測、製品別の市場セグメンテーション、地域別情勢、促進要因と課題、ベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 売り手の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競合の脅威
• 市況

第5章 市場セグメンテーション：製品別

• 市場セグメント
• 製品別の比較
• 標的療法：市場規模と予測
• 化学療法：市場規模と予測
• 製品別の市場機会

第6章 顧客情勢

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別の比較
• 北米：市場規模と予測
• 欧州：市場規模と予測
• アジア：市場規模と予測
• その他の地域：市場規模と予測
• 米国：市場規模と予測
• カナダ：市場規模と予測
• ドイツ：市場規模と予測
• インド：市場規模と予測
• 英国：市場規模と予測
• 地域情勢別の市場機会

第8章 促進要因、課題、動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AstraZeneca Plc
• Bristol Myers Squibb Co.
• Cipla Ltd.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Fresenius Kabi AG
• Intas Pharmaceuticals Ltd.
• Merck and Co. Inc.
• Sanofi SA
• Viatris Inc.

第11章 付録

Technavio has been monitoring the oral cancer therapeutics market and it is poised to grow by $ 1.14 bn during 2022-2026 decelerating at a CAGR of 7.5% during the forecast period. Our report on the oral cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence and prevalence of oral cancer, increasing risk factors of oral cancer, and growing awareness about oral cancer.

The oral cancer therapeutics market analysis includes product segment and geographic landscape.

Technavio's oral cancer therapeutics market is segmented as below:

By Product

• targeted therapy
• chemotherapy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in R and D of new drugs as one of the prime reasons driving the oral cancer therapeutics market growth during the next few years. Also, the development of a nanotechnology-based drug delivery system, and patient assistance program will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the oral cancer therapeutics market covers the following areas:

• Oral cancer therapeutics market sizing
• Oral cancer therapeutics market forecast
• Oral cancer therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oral cancer therapeutics market vendors that include Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Cipla Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Lupin Ltd., Merck and Co. Inc., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc. Also, the oral cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product
• 5.3 Targeted therapy - Market size and forecast 2021-2026
• Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
• 5.4 Chemotherapy - Market size and forecast 2021-2026
• Exhibit 32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Product
• Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Canada - Market size and forecast 2021-2026
• Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.9 Germany - Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.10 India - Market size and forecast 2021-2026
• Exhibit 70: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on India - Year-over-year growth 2021-2026 (%)
• 7.11 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 AstraZeneca Plc
• Exhibit 85: AstraZeneca Plc - Overview
• Exhibit 86: AstraZeneca Plc - Product / Service
• Exhibit 87: AstraZeneca Plc - Key news
• Exhibit 88: AstraZeneca Plc - Key offerings
• 10.4 Bristol Myers Squibb Co.
• Exhibit 89: Bristol Myers Squibb Co. - Overview
• Exhibit 90: Bristol Myers Squibb Co. - Product / Service
• Exhibit 91: Bristol Myers Squibb Co. - Key offerings
• 10.5 Cipla Ltd.
• Exhibit 92: Cipla Ltd. - Overview
• Exhibit 93: Cipla Ltd. - Business segments
• Exhibit 94: Cipla Ltd. - Key news
• Exhibit 95: Cipla Ltd. - Key offerings
• Exhibit 96: Cipla Ltd. - Segment focus
• 10.6 Eli Lilly and Co.
• Exhibit 97: Eli Lilly and Co. - Overview
• Exhibit 98: Eli Lilly and Co. - Product / Service
• Exhibit 99: Eli Lilly and Co. - Key offerings
• 10.7 F. Hoffmann La Roche Ltd.
• Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus
• 10.8 Fresenius Kabi AG
• Exhibit 105: Fresenius Kabi AG - Overview
• Exhibit 106: Fresenius Kabi AG - Business segments
• Exhibit 107: Fresenius Kabi AG - Key news
• Exhibit 108: Fresenius Kabi AG - Key offerings
• Exhibit 109: Fresenius Kabi AG - Segment focus
• 10.9 Intas Pharmaceuticals Ltd.
• Exhibit 110: Intas Pharmaceuticals Ltd. - Overview
• Exhibit 111: Intas Pharmaceuticals Ltd. - Product / Service
• Exhibit 112: Intas Pharmaceuticals Ltd. - Key offerings
• 10.10 Merck and Co. Inc.
• Exhibit 113: Merck and Co. Inc. - Overview
• Exhibit 114: Merck and Co. Inc. - Business segments
• Exhibit 115: Merck and Co. Inc. - Key news
• Exhibit 116: Merck and Co. Inc. - Key offerings
• Exhibit 117: Merck and Co. Inc. - Segment focus
• 10.11 Sanofi SA
• Exhibit 118: Sanofi SA - Overview
• Exhibit 119: Sanofi SA - Business segments
• Exhibit 120: Sanofi SA - Key news
• Exhibit 121: Sanofi SA - Key offerings
• Exhibit 122: Sanofi SA - Segment focus
• 10.12 Viatris Inc.
• Exhibit 123: Viatris Inc. - Overview
• Exhibit 124: Viatris Inc. - Business segments
• Exhibit 125: Viatris Inc. - Key offerings
• Exhibit 126: Viatris Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 127: Inclusions checklist
• Exhibit 128: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 129: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 130: Research methodology
• Exhibit 131: Validation techniques employed for market sizing
• Exhibit 132: Information sources
• 11.5 List of abbreviations
• Exhibit 133: List of abbreviations
• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Product - Market share 2021-2026 (%)
• Exhibits25: Data Table on Product - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Product
• Exhibits27: Data Table on Comparison by Product
• Exhibits28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Product ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on India - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: AstraZeneca Plc - Overview
• Exhibits86: AstraZeneca Plc - Product / Service
• Exhibits87: AstraZeneca Plc - Key news
• Exhibits88: AstraZeneca Plc - Key offerings
• Exhibits89: Bristol Myers Squibb Co. - Overview
• Exhibits90: Bristol Myers Squibb Co. - Product / Service
• Exhibits91: Bristol Myers Squibb Co. - Key offerings
• Exhibits92: Cipla Ltd. - Overview
• Exhibits93: Cipla Ltd. - Business segments
• Exhibits94: Cipla Ltd. - Key news
• Exhibits95: Cipla Ltd. - Key offerings
• Exhibits96: Cipla Ltd. - Segment focus
• Exhibits97: Eli Lilly and Co. - Overview
• Exhibits98: Eli Lilly and Co. - Product / Service
• Exhibits99: Eli Lilly and Co. - Key offerings
• Exhibits100: F. Hoffmann La Roche Ltd. - Overview
• Exhibits101: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits102: F. Hoffmann La Roche Ltd. - Key news
• Exhibits103: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits104: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits105: Fresenius Kabi AG - Overview
• Exhibits106: Fresenius Kabi AG - Business segments
• Exhibits107: Fresenius Kabi AG - Key news
• Exhibits108: Fresenius Kabi AG - Key offerings
• Exhibits109: Fresenius Kabi AG - Segment focus
• Exhibits110: Intas Pharmaceuticals Ltd. - Overview
• Exhibits111: Intas Pharmaceuticals Ltd. - Product / Service
• Exhibits112: Intas Pharmaceuticals Ltd. - Key offerings
• Exhibits113: Merck and Co. Inc. - Overview
• Exhibits114: Merck and Co. Inc. - Business segments
• Exhibits115: Merck and Co. Inc. - Key news
• Exhibits116: Merck and Co. Inc. - Key offerings
• Exhibits117: Merck and Co. Inc. - Segment focus
• Exhibits118: Sanofi SA - Overview
• Exhibits119: Sanofi SA - Business segments
• Exhibits120: Sanofi SA - Key news
• Exhibits121: Sanofi SA - Key offerings
• Exhibits122: Sanofi SA - Segment focus
• Exhibits123: Viatris Inc. - Overview
• Exhibits124: Viatris Inc. - Business segments
• Exhibits125: Viatris Inc. - Key offerings
• Exhibits126: Viatris Inc. - Segment focus
• Exhibits127: Inclusions checklist
• Exhibits128: Exclusions checklist
• Exhibits129: Currency conversion rates for US$
• Exhibits130: Research methodology
• Exhibits131: Validation techniques employed for market sizing
• Exhibits132: Information sources
• Exhibits133: List of abbreviations